#8: NOTABLES: Resignation, Innovation, Incarceration, Recognition, and Acclamation
Jeremy Levin, D.Phil., stepped down in October as CEO of Teva Pharmaceutical Industries after just…
Jeremy Levin, D.Phil., stepped down in October as CEO of Teva Pharmaceutical Industries after just…
Grosse déception pour Sanofi. Le groupe pharmaceutique français a annoncé hier que les autorités sanitaires…
Thermo Fisher bagged the year’s biggest deal in April when it agreed to acquire Life…
A divided U.S. Supreme Court in June sided with the state of Maryland, and much…
Round and round big pharma cost-cutting goes, and where (and when) the layoffs stop, nobody…
The initial public offering (IPO) market finally delivered on years of revival hype by roaring…
Companies looking to patent human genes won a mixed verdict from the U.S. Supreme Court…
Selon plusieurs sources, la fin de l’or c’est pour dans 10 ans! La production totale d’or…
Big money, big data, and some big layoffs made the biggest headlines in biopharma during…
Hepatitis C saw a few new drugs approved by FDA—including Olysio (simeprevir) from Johnson &…